Podcasts about Aorta

Dr. Adam Power, co-founder and Chief Medical Officer at Front Line Medical Technologies, shares his fascinating journey from a background in vascular surgery to developing COBRA-OS, a groundbreaking device for hemorrhage control. He discusses the challenges and milestones in bringing this life-saving technology to market, the impact of the device in trauma and emergency care, and innovative future applications, including its unexpected use in non-traumatic cardiac arrest.    Guest links: https://frontlinemedtech.com/ Charity supported: Canadian Cancer Society Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 064 - Dr. Adam Power [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Dr. Adam Power. Dr. Power is a leader in innovative medical devices for trauma and emergency care that is committed to lowering the barriers and bleeding control and resuscitation. Dr. Power was instrumental in the development of COBRA-OS, drawing on his unique clinical viewpoint and expertise to ensure utmost patient safety and assist with the company's global expansion. In addition to his current role as co-founder and Chief Medical Officer at Front Line Medical Technologies Incorporated, Dr. Adam Power is a vascular surgeon in the division of vascular surgery at Western University, which he joined in the fall of 2012, and he is involved in all aspects of academics and clinical care. Also, Front Line was just named the 2025 Medical Device Technology Company of the Year, so I definitely wanted to highlight that too. All right. Well, thank you so much for being here today, Adam. I'm so delighted to speak with you. [00:01:55] Dr. Adam Power: Yes, it's a pleasure to be here. Thank you. [00:01:57] Lindsey Dinneen: Of course. Well, I'd love if you would start by sharing a little bit about yourself, your background, and what led you to what you're doing today. [00:02:05] Dr. Adam Power: Sure, I'd love to. So I'm a Canadian. I grew up on the east coast of Canada and was always interested in science and math and those types of things. I think, importantly, I grew up with an identical twin brother as well. So we really didn't know what we wanted to do with our lives, and ultimately we're good in science and math and ended up in medicine. And then both of us, when we got into medicine, we weren't sure exactly what we wanted to do in medicine, and ultimately both of us became surgeons. He became a urology surgeon, and I became a vascular surgeon, where we joke that we're both plumbers. I deal with the red stuff and he's the yellow stuff. But I did my initial medical school out on the east coast of Canada and then I did my general surgery training, which also involved trauma training, and then did a Master's of Bioscience Enterprise, which was basically biotech business from the University of Cambridge in the UK. When I finished my general surgery training, I continued on and did vascular surgery training at Mayo Clinic down in the US, and since that time after graduating from there, I've been at Western University in London, Ontario, Canada, for the past 13 years practicing as a vascular surgeon and an academic vascular surgeon. But when I was here at Western, I was always interested in innovation. I filed my first patent as a resident way back when, and have filed many over the years. But ultimately, if I was ever gonna see anything that came outta my head and was actually used in a patient or I could actually use in a patient, I figured I'd have to do it. I knew that I couldn't do it by myself. And so, I was very fortunate to meet my co-founder Dr. Asha Parekh. She's a PhD, biomedical engineer, extremely smart jack of all trades, and we teamed up now about eight years ago. We met here at Western, teamed up and really took an idea right out of our heads and patented it and raised money for it, prototyped it, brought it all through the regulatory steps to approvals, built a quality system and ultimately got it out onto the market in Canada, US, Europe, now Australia, and more to come. So the commercialization piece is what we've been focusing on over the past three years. And it's been really fun, but very exhausting but very rewarding as well. I think I'll stop there because I've been blathering on, but... [00:04:39] Lindsey Dinneen: No, it's fantastic. I really appreciate it. Plus, it's really fun to hear about your trajectory and so, okay, so you've teased us a little bit about this company of yours and this innovation of yours. Can you now share a little bit more about that and the development of it over time? [00:04:55] Dr. Adam Power: Yes, of course. Well, I mean, thing that we recognized early on is, and I'll just explain how I normally explain it, is if you have bleeding, it's a hemorrhage control device. And so if you have bleeding in your extremities, then you can often either put pressure on it or you can put a tourniquet on it. The problem when you have internal bleeding in the torso is that you can't actually put direct pressure on it, and there's no tourniquet that necessarily works for intraabdominal, intrathoracic bleeding. And when people bleed to death before coming to hospital, I mean, they're bleeding in these areas. You can empty almost your entire blood volume into your chest or into your abdomen. And this does account for a significant number of fatalities in all environments, basically in the trauma environment. That's military, that's pre-hospital, that's any time that that people are bleeding from internal organs. And so, because this is such a problem, the old fashioned way to fix it is to open up someone's chest and put a clamp on the aorta. So what does that do? Is it basically above the clamp, keeps blood flowing. The remaining blood in the body keeps blood flowing to the brain and the heart, keep you alive. And then below the clamp, it stops sort of the hemorrhaging from the spleen or the liver or whatever. So there's two things going on. One above the clamp and two below the clamp. But opening up somebody's chest in, you know, side of the road or in the emergency department really is impossible. You need highly skilled people like vascular surgeons like myself to be able to do this. And even if we were at the side of the road, we don't have the resources available to keep a patient alive. So there is this idea that we could do this minimally invasively, sort of accomplish this through minimally invasive means. And this, the idea of doing REBOA, which is an acronym-- Resuscitative Endovascular Balloon Occlusion of the Aorta-- came into being. This was probably 15, 20 years ago now. It wasn't necessarily a new idea. It had been done since the Korean War. There was somebody actually put a balloon up into someone's aorta to stop bleeding, but it came back again and was starting to be used a little bit more because. And so really the idea is to, through the femoral artery in your groin where you can feel a pulse, you introduce initially a sheath, which is your access point, and then you place the device up through the sheath, up into the aorta and inflate a balloon in the aorta. So instead of an external clamp, it's an internal balloon clamp that keeps blood flowing above the balloon and stops the blood flowing from below the balloon. Initially these devices were as big as my baby finger, like they were massive. And so if you put them in and you took it out, there was a big hole in the artery, had to cut down on the artery and repair the artery. But as it got more and more advanced and technology advanced, they become smaller and smaller. So that's really where we came in. The initial devices were 12 French, about the size of my baby finger. And then it advanced to Seven French and all of a sudden Seven French-- and these are diameter, French sizes are basically diameter-- and so when it went from 12 to seven French, now we could start doing it through the skin without actually cutting down on the artery. But that Seven French size was still very large and you're putting this in the hands of people that don't do this all the time. And so, we had the idea to bring it down even further now to Four French. And so this is essentially the size of an IV. And so you put a tiny little IV in somebody's femoral artery. And lots of different people can do that. And then you advance the device up in, inflate the balloon and you can magically occlude the aorta. In our first study that we did, the first inhuman study, we averaged about just over a minute to occlude someone's aorta, which was really fast to be able to get that amount of control that quickly. So that, that was really been the advancement is to decrease the access size, make this whole procedure simpler so that so that we can essentially save more lives. [00:09:08] Lindsey Dinneen: Okay, so thank you so much for sharing a little bit about that. Can you tell me about the beginnings of this innovation and how you brought it to market? Because it's really wonderful to hear all the success, and I'm so excited to hear that it's spreading, you have presence all over the place now. But you know, that's not an easy pathway. And I'm curious if you could walk us through a little bit about that decision to go, "You know what? We have a solution to a known problem, we can make this happen." And then how did you actually go about doing that? [00:09:42] Dr. Adam Power: Yeah. I think, I mean, I make it sound fairly straightforward, like a nice story, but it certainly was not that. I mean, we were very lucky I would say, that we had a lot of great advisors and mentors that we figured that we try not to fail early, fail fast. We wanted to make this one as successful as possible. So before we made any decision, we often would consult our mentors. And I'm a surgeon. I like to shoot first, ask questions later. My partner is not. And so I think we, we strike an excellent balance between not just the engineering and clinical side of things, but also from driving a business forward, getting all the information, but helping to get decisions made and moving forward. You know, starting out, we really had to choose the right sort of fit for what we wanted to pursue. We like to say it checked all the boxes. It checked all the boxes as far as even where we are. We're in Canada, we're not in a tech triangle where there's tons of funding opportunities. We knew we would be limited from a funding perspective, so we couldn't choose something that necessarily required a hundred million dollars to start up. So, you know, we had this device that we knew that we could fundraise for it. And then once it was fundraised, it was simple enough that we could get it manufactured. We chose to go the OEM route for the original equipment manufacturer, so we didn't have to build a manufacturing facilities ourselves. And then really from there, and building a quality system in the regulatory, we did work with a lot of consultants, that was both positive and negative experience. We had great consultants. We had not so great consultants. But really what our our goal was, is to learn the process ourselves. And so there's always manuals for things, even from the FDA perspective. They give out great documentation about what is supposed to go into an FDA application. And we dug into that. We really tried to understand. We did not trust anyone. That's one of my rules in surgery is, "don't trust anyone, not even myself." So we really didn't trust our consultants, and we tried to double check and triple check everything so that we didn't make mistakes. And of course, we did make mistakes and had to go back to the drawing board a few times. But as much as we wanted to get this out there, we really did wanna learn the process and know the process because ultimately we're the ones that are responsible to the patients in the end, and we needed to make sure that we had a handle on each and every step of the way. We, of course, because of that, were maybe not as quick as we could have been but in other places we became more efficient because, as we learned the process, getting feedback back and doing it right the first time, it really made a difference. So. [00:12:39] Lindsey Dinneen: Yeah, absolutely. Of course. Yeah, and I appreciate you going into a little bit more of the nitty gritty details 'cause it is so fun to hear the success stories, but of course, as you go along, there's that pathway to success. And it's helpful to understand that yeah, it's gonna be potentially a long road, sometimes windy, sometimes weird, but at the same time that it is possible. So as you look to the future with your company, what are you thinking of in terms of the future? Are you going to continue down this pathway and continue with iterations of this device? Are you thinking of new devices to introduce as well? Or, what are your thoughts for the future? [00:13:18] Dr. Adam Power: Yeah. And I have to be very careful what I say here, obviously. I can share generically what our thoughts are. We love this. Ultimately there was no better feeling than to use-- I mean, I've used my device to save a patient. And, you know, I would say that Asha, who's my co-founder, she cares. I'm a physician, but she cares about the patients just as much as I do, as does everyone in our company, which is really quite rewarding. But the future, what does the future hold? We really want this to get to everywhere. Yes, we're in lots of different countries ,have commercialized really all around the globe, but we really wanna go deeper into a lot of these geographies and really help as many people as possible. We realize that we can't do it on our own and are gonna need help. And so that's, we're in a growth phase right now of our company and we're looking for strategic collaboration. We're looking for those opportunities to deepen our ties and in all the different geographies. That being said, we are inventors and of course we have an idea every day about what we could improve on. But as far as the pipeline goes for our company, we are focusing on some very specific up and coming applications that we hope to have in the next couple of years. And I also wanna say that, I talked about trauma and bleeding, but the more exciting side of aortic occlusion has really been the applications. And you'd think, okay, it makes sense for trauma to be able to stop blood flow and stop bleeding. But some of our recent successes have been through postpartum hemorrhage. And there is this really, terrible condition called placenta accreta, where the placenta grows into the uterus and when you deliver the baby either by C-section or by delivery, and then the placenta attempts to be delivered, it tears, and you can have torrential bleeding. And, and so our device is being used in these women who are pregnant when inflicted with this condition and helping to decrease blood transfusions, helping to save a mother's life. So that's been really amazing. And then next on the horizon is strangely there's, it's not even a bleeding application. We've done some research and there's research going on globally about using aortic, minimally invasive aortic occlusion for non-traumatic cardiac arrest. And so if, which is really, again, it's like, "Oh my gosh, does this thing do everything? It might make your supper tonight if you're not careful." So it, so what happens there is that if somebody drops dead basically in front of you, and you start CPR, if you start pushing on their chest and pushing on their heart, you're pushing blood to the whole body. And the way you get someone back to life is if you can get the heart muscle oxygenated again. So if you put an aortic occlusion balloon up close to the heart, every time you push, you're directing blood right into the coronary arteries and right into the brain as well. And so what we're seeing is that there's increased return of spontaneous circulation rates when you do this with CPR. And there are different trials around the world that if this shows that there's an increase in survival or in better neurological survival, this will be the first time that we've really changed the script on cardiac arrest since advanced cardiac life support came out many years ago. So this, again, is very exciting for a simple device to be able to make that much impact in all these different areas. So, you know, we have a lot to focus on right now, even growing into the future because some of these, like cardiac arrest, are quite early on. So we don't wanna lose sight of this great original product, but we do think all the time about different pipeline ideas that could help other patients. [00:17:18] Lindsey Dinneen: Yeah, but, and to your point, even the amazing other use cases for this incredible device, like you said-- maybe it's gonna make us dinner next-- but the idea being that, who knows? I mean, there's so much more to discover even now, which makes me excited just to think about how many more use cases you could have for it and how many more people you could save. So, speaking of that, are there any stories that kind of stand out to you, moments that you've had where, you know, either through your day job, so to speak, being a vascular surgeon, but also being the co-founder of this company that really sort of affirmed to you that, "You know what? I am in the right place at the right time, in the right industry." Just those moments that really stick with you. [00:18:05] Dr. Adam Power: Yeah, I mean, it obviously all stems back to the patient and what patients are impacted. And I remember, the first time that the device was used at our hospital, one of the radiologists called me in and said, " We need to use one of these balloon occlusion devices for a patient that's been in an accident." And so I went in and I said, "I actually have the device that my partner and I created. We can use this for the patient." And so we started using it for the lady that was involved in a very serious accident, had a pelvic fracture, and she was a Jane Doe at that particular time. She was anonymous. And anyway, we noticed that she had actually had some vascular surgery done based on her angiograms, and I leaned over and I-- so she was sedated, but she was awake-- I said, "Have you had vascular surgery? Who's your vascular surgeon?" And she said, "It's Dr. Power. He's such a nice man." And so I was actually helping one of my patients. That was pretty crazy. [00:19:04] Lindsey Dinneen: Oh. [00:19:05] Dr. Adam Power: Also from my hospital, when I heard one of my junior residents was able to save someone's life. So, you know, junior residents are often good, but they're not trained surgeons. And so to have a simplistic device that one of my residents could actually place and help someone, that's pretty amazing too. There's also been times where like even the postpartum hemorrhage, we hear the first cases in the States of saving mother and baby. That's pretty incredible. Or that we donated some devices to the Ukraine conflict as well, and we heard that it saved some soldiers' lives as well. And there's different military groups that, that use our device and save soldiers. So it's all back to the patient. And hearing those success stories and hearing about somebody alive because of this particular device, because of all this effort that we've put in. I mean, it's really makes it worthwhile. It sounds kind of corny, but as a surgeon, I can help one person at a time, but as somebody involved in industry and medical device industry, I don't even have to be there. You know, this device can help long after I'm gone. The tricky part of it, being the Chief Medical Officer is, I usually only have to worry about my patients. Now I have to worry about everybody worldwide and the device being used. That was a little hard to wrap my head around initially, but yeah. [00:20:28] Lindsey Dinneen: Yeah, of course. But the ripple, the ripples, the impact that you get to have because of this device and because of your diligence getting it to market, because it isn't an easy path, and that's incredible. So thank you for doing the work that you're doing. That's not easy and it's very appreciated. This is incredible. So, yeah. So, okay. When you were growing up, let's say 8-year-old, Adam-- you know, you're having a good time doing whatever you like to do-- could you possibly have pictured yourself where you are now? [00:21:08] Dr. Adam Power: No, I don't think so. I mean, I, I. I came from a very small, like, small upbringing and, you know, in my family I had absolutely lovely family members, but they really, apart from my aunt, they weren't overly educated. And so I really didn't know what it took to be successful in life, really. I had work ethic from my parents, that's for sure. And so that's what they bred into me. And all I knew is that I was gonna work as hard as I could, and I figured that as long as I keep working-- and I was lucky to have some brains as well-- then I figured things would fall into place. They honestly haven't fallen into place exactly how I pictured them as I grew older and what it would look like. But I'm certainly thankful for where I am right now, and what is the next five years or 10 years gonna look like? I have no idea. And I guess I just don't even picture it. I have goals, but I also know that those goals change depending on circumstances. And you need, as I'm growing into middle age-- I think I'm beyond middle age now-- I'm thinking about midlife crisis and things like that. I get into philosophy and there's like telic and atelic things and so, it's sounds, again, it's about the path and the journey. It's not about the ultimate goal because, having reached a lot of these successes, that good feeling lasts for maybe a day or half a day. And you think you know, I spent all these years coming with the, with our device, getting our device to market and getting FDA approval and like, oh my gosh, like, you'd think, I'd feel so great about that. And it did. It felt great, but you wake up the next day and you gotta keep going. So you have to enjoy the journey and that's really what it's the wisdom that comes with age is trying to enjoy the journey as much as possible and not focus too much beyond that. [00:23:09] Lindsey Dinneen: Yeah. Yeah, and I think that's really good advice too, in that it is because the daily life isn't usually all the celebration and successes. I mean, that does happen and those are good moments, but because the vast majority of our life is spent on the journey component of it, and going through those peaks and valleys, it is important to find something you love and feel that you can make an impact in. So I'm so thankful that this is what you've chosen to do. So pivoting the conversation a little bit just for fun, imagine that you're to be offered a million dollars to teach a masterclass on anything you want. Could be within your industry, but it doesn't have to be. What would you choose to teach? [00:23:55] Dr. Adam Power: And would that mean that I was an expert in it? [00:23:58] Lindsey Dinneen: Well, certainly if you're getting paid a million dollars, somebody has decided you aren't an expert at it. How about that? [00:24:05] Dr. Adam Power: Okay. Well. Can I pretend like I'm an expert in it? There's something that I really love, but I'm not I'm probably not an expert in it. It would be, I would teach a masterclass in DJing. Isn't that strange? I know it's so random. [00:24:21] Lindsey Dinneen: Oh my goodness! Tell me more! [00:24:23] Dr. Adam Power: Well, I mean, I love music. I've, I grew up playing lots of sports and never was involved in music. And, and I've always appreciated music and art, but I was never able to do it. And, you know, growing up I did love sort of all types of music and then even electronic music and it just somehow talked to me. So I started DJing electronic music basically when I was around med school and have always loved it now, and when I was over in England, I DJ'ed on the campus radio and also DJ'd in a club. It was really fun and it sounds pretty silly to be talking about this when I have these other things that are on the go. But honestly, being able to share space with other human beings these days, and actually having a good time and having it not be stressful and having it be only, you know, everybody's wishing others to have a good time. There's not many people that go out sort of dancing into electronic music that are thinking bad things about other people. Really they're just out for a good time. And so being able to steer that whole music and scene is pretty awesome. And I do love it. And I don't DJ as much as I used to, but I still do different events, usually Christmas parties for the operating room. I'll do the typically wedding sort of DJ, but then they always, 'cause they know me, they let me do an hour long electronic set, which is like hardcore electronic. But then I go back to the regular stuff. But I would want to teach a masterclass in DJing. [00:25:56] Lindsey Dinneen: That is awesome. How exciting. Oh my gosh, I love that. And I think you're right. Music brings us together and it's a wonderful way to, to share a little bit of joy. [00:26:07] Dr. Adam Power: Yeah. [00:26:08] Lindsey Dinneen: Yeah. Okay. And then how do you wish to be remembered after you leave this world? [00:26:15] Dr. Adam Power: I, so number one is I don't, again, with my midlife crisis, I've actually been trying to eliminate my ego as much as possible. And so when people talk about legacy, it actually gives me the hives these days to be quite honest, because I don't like that because I think you're focused a lot on yourself. In my opinion, a lot of legacy is all about you. The way that I would wanna be remembered, though, is truly that I was kind and compassionate to everyone that I met, and that I stood for something, and that I left the world a better place. [00:26:57] Lindsey Dinneen: Yeah, those are wonderful things to want to be remembered for, absolutely. And then final question, what is one thing that makes you smile every time you see or think about it? [00:27:09] Dr. Adam Power: My kids. My son Kai and my daughter Saoirse. They are the light of my life. And I, you would think that with how busy I am ,you know, those things would deprioritize, but they truly are the one thing in my life that makes me smile when I get up in the morning. [00:27:30] Lindsey Dinneen: Oh, that's wonderful. Well, that is absolutely incredible. I loved getting to meet you and speak with you a little bit today. Thank you so much for sharing about your journey. Thank you for sharing about your incredible device and your bits of wisdom along the way. The idea of we've gotta enjoy the experience, the path, the journey. And I just really appreciate you spending some time with us. So thank you for everything you're doing to change lives for a better world. [00:27:59] Dr. Adam Power: Oh, well, thank you for giving me the opportunity to speak with you. It was absolutely lovely chatting with you today. [00:28:05] Lindsey Dinneen: Wonderful. Well, thank you again so much. Thank you also to listeners who are tuning in, and if you're as inspired as I am, I would love it if you would share this episode with a colleague or two and we'll catch you next time. [00:28:20] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Aortopatia ou valvopatia ? Bivalvulada ou doença Aórtica?

Esse tópico foi abordado na edição 97 do Guia TdC. Para saber mais, acesse: https://www.tadeclinicagem.com.br/guia/335/diretriz-de-doencas-da-aorta-esc-2024/

Agradece a este podcast tantas horas de entretenimiento y disfruta de episodios exclusivos como éste. ¡Apóyale en iVoox! Hoy os traigo una historia que combina lo cotidiano con lo macabro, lo absurdo con lo inquietante. Se trata de "Tierra Gratis", un relato de Charles Beaumont. Beaumont, conocido por sus contribuciones a la serie The Twilight Zone, nos presenta en este cuento al señor Aorta, un hombre que, en su afán por obtener algo a cambio de nada, acepta tierra gratuita de un cementerio para su jardín. Lo que comienza como una oportunidad aparentemente inofensiva pronto se transforma en una pesadilla surrealista. - Narración: Juan Carlos Albarracín - Locución Sintonía: Antonio Runa - Música: Epidemic Sound, con licencia https://www.epidemicsound.com/track/gu691tVuel/ https://www.epidemicsound.com/track/VnhjuXTdMm/ - Ilustración: Pixabay, con licencia https://pixabay.com/es/illustrations/oto%C3%B1o-cementerio-tumba-l%C3%A1pidas-7286288/ Los Cuentos de la Casa de la Bruja es un podcast semanal de audio-relatos de misterio, ciencia ficción y terror. Cada viernes, a las 10 de la noche, traemos un nuevo programa. Alternamos entre episodios gratuitos para todos nuestros oyentes y episodios exclusivos para nuestros fans. ¡Si te gusta nuestro contenido suscríbete! Y si te encanta considera hacerte fan desde el botón azul APOYAR y accede a todo el contenido exclusivo. Tu aporte es de mucha ayuda para el mantenimiento de este podcast. ¡Gracias por ello! Mi nombre es Juan Carlos. Dirijo este podcast y también soy locutor y narrador de audiolibros, con estudio propio. Si crees que mi voz encajaría con tu proyecto o negocio contacta conmigo y hablamos. :) Contacto profesional: info@locucioneshablandoclaro.com www.locucioneshablandoclaro.com También estoy en X y en Bluesky: @VengadorT Y en Instagram: juancarlos_locutor Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Commentary by Dr. Jian'an Wang.

Zwei Männer, ein unglaubliches Schicksal: Dominik Kettner und Armin Bützberg überlebten beide eine gerissene Aorta und berichten von ihrer Reise zwischen Leben und Tod. Ein bewegendes Gespräch über die wichtigsten Lektionen des Lebens und was uns wirklich mit der anderen Seite verbindet.

Franz Liszt, Johannes Brahms, Béla Bartók, Zoltan Kódaly oder Johann Strauss Junior, sie alle wären ohne sie deutlich ärmer: Ohne Sinti und Roma gäbe es keinen Gypsy-Swing und keinen Flamenco, keine Balkan-Brassbands und weitaus weniger slawische Balladen, keine cubanische Rumba, keine Saz und keine Marianne Rosenberg. Henry Altmann über die Aorta des musikalischen Transports, die Musik der Roma und Sinti.

Part 2 of my review of aortic imaging for radiology board exams. Download the free study guide and check out other helpful content at theradiologyreview.com. Prepare to succeed!Mentioned in this episode:Thieme Today's podcast is brought to you by Thieme Synaptiq Radiology Spaced-Repetition Flashcards. Study better with pre-made, physician-curated flashcard decks in an easy-to-use app. Designed by a resident, Radiology Spaced-Repetition Flashcards are made to boost learning and save time. Visit Thieme.com/RadFlashcards to learn more.Thieme Synaptic

A aorta é o maior vaso sanguíneo do corpo. Cabe a ela levar o sangue do coração até a cabeça e para o abdômen e pernas. Algumas vezes, as paredes da aorta podem apresentar uma dilatação que supera 50% do seu diâmetro normal na porção final, localizada no abdômen. Nesses casos, trata-se de um aneurisma de aorta abdominal. Para falar sobre o assunto, Jota Batista conversa no Canal Saúde com o cardiologista Carlos Japhet.

Erica Groshen, former Commissioner of the U.S. Bureau of Labor Statistics (BLS) uses the acronym AORTA to characterize good data; Accurate, Objective, Relevant, Trustworthy, and Accessible. This is apt since good data are the lifeblood of economic decision-making. But what happens if statistics are compromised by reduced staffing and resources, or by politically motivated manipulation? Erica joins EconoFact Chats to discuss the history and the role of the BLS, the importance of good data for decision-making by government, businesses, and families, and her concerns about political interference degrading the integrity of government statistics. Erica served as the Commissioner of the U.S. Bureau of Labor Statistics from 2013 to 2017. She is currently Senior Economics Advisor at the Cornell School of Industrial and Labor Relations, and a Research Fellow at the Upjohn Institute.

Barack OLlama update, The Name As In Game, Saus Toss, Late To The Party AND an all New TimewasterSee omnystudio.com/listener for privacy information.

WHILE MASTURBATING!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This special issue of JACC is dedicated to the essential role of cardiovascular surgery in advancing modern cardiology.

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241300881

Part 1 of my review of imaging findings of the aorta for radiology board review. Check out the free study guide at www.theradiologyreview.com. Prepare to succeed!Mentioned in this episode:Board Vitals Discount CodeReady to ace your exams with Board Vitals? Unlock a 10% discount when you use code RADREVIEW at checkout! Don't miss out—start your journey to success today. Terms and conditions apply.

This week we review a work from the department of cardiology and department of cardiac surgery at Boston Children's Hospital on late hypertension in patients following coarctation repair. Late hypertension has been associated previously with late transverse aortic arch Z score but can this be predicted by the immediate postoperative transverse aortic arch Z score also? What factors account for late hypertension in the coarctation patient? Should more patients have their aorta repaired from a sternotomy? Dr. Sanam Safi-Rasmussen, who is a PhD candidate at Copenhagen University, shares her insights from a work she performed while a research fellow at Boston Children's Hospital. DOI: 10.1016/j.jtcvs.2024.08.049

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aorta and Branches⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Gastrointestinal section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

This episode covers coarctation of the aorta.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/coarctation/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Tratamento dos aneurismas de aorta além da cirurgia - Diretriz ESC 2024 by Cardiopapers

Rastreamento dos aneurismas - Diretriz Aorta ESC 2024 by Cardiopapers

Nesse episódio a Dra. Eduarda Campos Menegaço discute o reconhecimento e manejo da hipertensão intracraniana na sala de emergência. Ela é Residente de terceiro ano do programa de medicina de emergência do HC-FMUSP. Mais informações: Se você gosta do nosso podcast, por favor compartilhe o nosso conteúdo em redes sociais e nos avalie no iTunes. Isso é importante para que mais pessoas conheçam o nosso trabalho. Mande feedback para 15minutos.emergencia@gmail.com. Siga-nos nas redes sociais. Dra. Eduarda Menegaço está no Instagram em @dudamenegaco Dr. Julio Marchini está no Instagram em @emergency_drops #15minutosememergencia

Aneurisma da Aorta - Síndromes genéticas e Bicúspide - Diretriz ESC 2024 by Cardiopapers

Nem só de doença coronariana e valvopatias vive o cardiologista! No mundo há mais pacientes com cardiopatias congênitas adultos do que crianças! E claro que você precisa saber sobre a Coarctação de Aorta (CoAo), a mais comum delas. Dois convidados especiais com experiência no diagnóstico e tratamento de neonatos, crianças e adultos foram os convidados para a melhor conversa que se pode ter sobre o diagnóstico e tratamento da CoAo: Dr. Raul Arrieta e Dra. Renata Cassar. Imperdível!

Im Sommer 2024 wird die Riedbahn monatelang gesperrt. Die Zeit der Generalsanierung ist angebrochen. Aber wie konnte das Netz überhaupt so kaputt gehen? Sommer 2024: Die Riedbahn – die „Aorta des Schienennetzes“ – wird saniert und die Strecke zwischen Frankfurt und Mannheim monatelang gesperrt. Wie konnte das Netz überhaupt so kaputt gehen, dass eine der wichtigsten Bahnstrecken nur durch diese Operation zu retten ist? Und wird jetzt alles gut? Host Charlotte und Reporterin Joana treffen zwei, die die Riedbahn in- und auswendig kennen. Michael hat lange Zeit Weichen gestellt, Thomas führt Buch über alle Störungen im Netz. Sie schicken Charlotte und Joana in den südhessischen Dschungel. Hier in Zwingenberg soll es ein stillgelegtes Gleis geben, das für vieles steht, was in den letzten Jahrzehnten mit dem Netz schiefgelaufen ist. Seit der Gründung der Deutschen Bahn AG. Podcast-Tipp vom Teurer Fahren-Team: Wir empfehlen Euch, bei Eva Schulz in den Zug einzusteigen. Also ihren wunderbaren Podcast Deutschland 3000 regelmäßig zu hören. Wenn Sie mit Gästen wie Joko Winterscheidt und Satou Sabally spricht. Und manchmal sogar Umfragen zur Deutschen Bahn macht: https://www.ardaudiothek.de/sendung/deutschland3000-ne-gute-stunde-mit-eva-schulz/66261430/ >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/teurer-fahren-episode-1-riedbahn-generalsanierung-ueberholgleis

Im Sommer 2024 wird die Riedbahn monatelang gesperrt. Die Zeit der Generalsanierung ist angebrochen. Aber wie konnte das Netz überhaupt so kaputt gehen? Sommer 2024: Die Riedbahn – die „Aorta des Schienennetzes“ – wird saniert und die Strecke zwischen Frankfurt und Mannheim monatelang gesperrt. Wie konnte das Netz überhaupt so kaputt gehen, dass eine der wichtigsten Bahnstrecken nur durch diese Operation zu retten ist? Und wird jetzt alles gut? Host Charlotte und Reporterin Joana treffen zwei, die die Riedbahn in- und auswendig kennen. Michael hat lange Zeit Weichen gestellt, Thomas führt Buch über alle Störungen im Netz. Sie schicken Charlotte und Joana in den südhessischen Dschungel. Hier in Zwingenberg soll es ein stillgelegtes Gleis geben, das für vieles steht, was in den letzten Jahrzehnten mit dem Netz schiefgelaufen ist. Seit der Gründung der Deutschen Bahn AG. Podcast-Tipp vom Teurer Fahren-Team: Wir empfehlen Euch, bei Eva Schulz in den Zug einzusteigen. Also ihren wunderbaren Podcast Deutschland 3000 regelmäßig zu hören. Wenn Sie mit Gästen wie Joko Winterscheidt und Satou Sabally spricht. Und manchmal sogar Umfragen zur Deutschen Bahn macht: https://www.ardaudiothek.de/sendung/deutschland3000-ne-gute-stunde-mit-eva-schulz/66261430/ >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/teurer-fahren-episode-1-riedbahn-generalsanierung-ueberholgleis

Im Sommer 2024 wird die Riedbahn monatelang gesperrt. Die Zeit der Generalsanierung ist angebrochen. Aber wie konnte das Netz überhaupt so kaputt gehen? Sommer 2024: Die Riedbahn – die „Aorta des Schienennetzes“ – wird saniert und die Strecke zwischen Frankfurt und Mannheim monatelang gesperrt. Wie konnte das Netz überhaupt so kaputt gehen, dass eine der wichtigsten Bahnstrecken nur durch diese Operation zu retten ist? Und wird jetzt alles gut? Host Charlotte und Reporterin Joana treffen zwei, die die Riedbahn in- und auswendig kennen. Michael hat lange Zeit Weichen gestellt, Thomas führt Buch über alle Störungen im Netz. Sie schicken Charlotte und Joana in den südhessischen Dschungel. Hier in Zwingenberg soll es ein stillgelegtes Gleis geben, das für vieles steht, was in den letzten Jahrzehnten mit dem Netz schiefgelaufen ist. Seit der Gründung der Deutschen Bahn AG. Podcast-Tipp vom Teurer Fahren-Team: Wir empfehlen Euch, bei Eva Schulz in den Zug einzusteigen. Also ihren wunderbaren Podcast Deutschland 3000 regelmäßig zu hören. Wenn Sie mit Gästen wie Joko Winterscheidt und Satou Sabally spricht. Und manchmal sogar Umfragen zur Deutschen Bahn macht: https://www.ardaudiothek.de/sendung/deutschland3000-ne-gute-stunde-mit-eva-schulz/66261430/ >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/teurer-fahren-episode-1-riedbahn-generalsanierung-ueberholgleis

Im Sommer 2024 wird die Riedbahn monatelang gesperrt. Die Zeit der Generalsanierung ist angebrochen. Aber wie konnte das Netz überhaupt so kaputt gehen? Sommer 2024: Die Riedbahn – die „Aorta des Schienennetzes“ – wird saniert und die Strecke zwischen Frankfurt und Mannheim monatelang gesperrt. Wie konnte das Netz überhaupt so kaputt gehen, dass eine der wichtigsten Bahnstrecken nur durch diese Operation zu retten ist? Und wird jetzt alles gut? Host Charlotte und Reporterin Joana treffen zwei, die die Riedbahn in- und auswendig kennen. Michael hat lange Zeit Weichen gestellt, Thomas führt Buch über alle Störungen im Netz. Sie schicken Charlotte und Joana in den südhessischen Dschungel. Hier in Zwingenberg soll es ein stillgelegtes Gleis geben, das für vieles steht, was in den letzten Jahrzehnten mit dem Netz schiefgelaufen ist. Seit der Gründung der Deutschen Bahn AG. Podcast-Tipp vom Teurer Fahren-Team: Wir empfehlen Euch, bei Eva Schulz in den Zug einzusteigen. Also ihren wunderbaren Podcast Deutschland 3000 regelmäßig zu hören. Wenn Sie mit Gästen wie Joko Winterscheidt und Satou Sabally spricht. Und manchmal sogar Umfragen zur Deutschen Bahn macht: https://www.ardaudiothek.de/sendung/deutschland3000-ne-gute-stunde-mit-eva-schulz/66261430/ >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/teurer-fahren-episode-1-riedbahn-generalsanierung-ueberholgleis

Nesse episódio a Dra. Helena Aiello Amat apresenta um caso que ela atendeu em localidade remota, como ela suspeitou do diagnóstico e o manejo da situação. Ela é Residente de terceiro ano do programa de medicina de emergência do HC-FMUSP. Mais informações: Se você gosta do nosso podcast, por favor compartilhe o nosso conteúdo em redes sociais e nos avalie no iTunes. Isso é importante para que mais pessoas conheçam o nosso trabalho. Mande feedback para 15minutos.emergencia@gmail.com. Siga-nos nas redes sociais. A Dra. Helena Aiello Amat está no instagram em @helena.amat Dr. Julio Marchini está no Instagram em @emergency_drops #15minutosememergencia

Diretriz Aorta - ESC 2024 - PARTE 2 by Cardiopapers

O básico sobre os aneurismas de aorta - Diretriz ESC 2024 by Cardiopapers

Diretriz Aorta - ESC 2024 - PARTE 1 by Cardiopapers

Well, there's a new fear unlocked.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Para falar sobre os aneurismas de aorta torácica, um tema muito requisitado por aqui, William Batah e Victor Bemfica se uniram ao convidado mais que especial, Dr. Vinícius Correia (@drviniciuscorreia ), especialista em miocardiopatias e doenças da aorta (InCor) e membro da plataforma de educação médica digital @emergenciasimm. O episódio está SENSACIONAL! Mandem suas dúvidas e compartilhem!

Reference: Jansen et al. Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial. JAMA. 2023 Date: June 10, 2024 Guest Skeptic: Dr. Rob Leeper is an intensivist, trauma surgeon, and general surgeon at Western University where he also serves as the director of the […] The post SGEM#443: Don't Stop Me Now – REBOA for Hemorrhage Control in Trauma Patients? first appeared on The Skeptics Guide to Emergency Medicine.

In this second of a two part podcast special Iain and Simon go through twenty of the top papers from the last year or so, as presented by Simon at the Big Sick Conference in Zermatt earlier this year. All the details and more discussion can be found on the blog site. In Part 2 they discuss papers about major haemorrhage, trauma, cardiac arrest and more.  In Part 1 they discuss all things airway, including where we should be intubating patients needing immediate haemorrhage control. VL vs DL, the effect of blade size on intubation success, whether small adult ventilation bags are better than larger versions, intubating comatose poisoned patients, and more.  Papers Jansen JO et al. Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial. JAMA. 2023 Nov 21;330(19):1862-1871. doi: 10.1001/jama.2023.20850. PMID: 37824132; PMCID: PMC10570916. Davenport R et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA. 2023 Nov 21;330(19):1882-1891. doi: 10.1001/jama.2023.21019. PMID: 37824155; PMCID: PMC10570921. PATCH-Trauma Investigators and the ANZICS Clinical Trials Group; Prehospital Tranexamic Acid for Severe Trauma. N Engl J Med. 2023 Jul 13;389(2):127-136. doi: 10.1056/NEJMoa2215457. Epub 2023 Jun 14. PMID: 37314244. Shepherd JM et al Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial. Intensive Care Med. 2023 Aug;49(8):922-933. doi: 10.1007/s00134-023-07135-3. Epub 2023 Jul 20. PMID: 37470832; PMCID: PMC10425486. Bouzat P et al. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial. JAMA. 2023 Apr 25;329(16):1367-1375. doi: 10.1001/jama.2023.4080. PMID: 36942533; PMCID: PMC10031505. Torres CM, Kent A, Scantling D, Joseph B, Haut ER, Sakran JV. Association of Whole Blood With Survival Among Patients Presenting With Severe Hemorrhage in US and Canadian Adult Civilian Trauma Centers. JAMA Surg. 2023 May 1;158(5):532-540. doi: 10.1001/jamasurg.2022.6978. Erratum in: JAMA Surg. 2023 Apr 5;: PMID: 36652255; PMCID: PMC9857728. Marsden MER, Kellett S, Bagga R, Wohlgemut JM, Lyon RL, Perkins ZB, Gillies K, Tai NR. Understanding pre-hospital blood transfusion decision-making for injured patients: an interview study. Emerg Med J. 2023 Nov;40(11):777-784. doi: 10.1136/emermed-2023-213086. Epub 2023 Sep 13. PMID: 37704359; PMCID: PMC10646861. Wohlgemut JM, Pisirir E, Stoner RS, Kyrimi E, Christian M, Hurst T, Marsh W, Perkins ZB, Tai NRM. Identification of major hemorrhage in trauma patients in the prehospital setting: diagnostic accuracy and impact on outcome. Trauma Surg Acute Care Open. 2024 Jan 12;9(1):e001214. doi: 10.1136/tsaco-2023-001214. PMID: 38274019; PMCID: PMC10806521. Cheskes S, Verbeek PR, Drennan IR, McLeod SL, Turner L, Pinto R, Feldman M, Davis M, Vaillancourt C, Morrison LJ, Dorian P, Scales DC. Defibrillation Strategies for Refractory Ventricular Fibrillation. N Engl J Med. 2022 Nov 24;387(21):1947-1956. doi: 10.1056/NEJMoa2207304. Epub 2022 Nov 6. PMID: 36342151. Siddiqua N, Mathew R, Sahu AK, Jamshed N, Bhaskararayuni J, Aggarwal P, Kumar A, Khan MA. High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial. Emerg Med J. 2024 Jan 22;41(2):96-102. doi: 10.1136/emermed-2023-213285. PMID: 38050078. Wilkinson-Stokes M, Betson J, Sawyer S. Adverse events from nitrate administration during right ventricular myocardial infarction: a systematic review and meta-analysis. Emerg Med J. 2023 Feb;40(2):108-113. doi: 10.1136/emermed-2021-212294. Epub 2022 Sep 30. PMID: 36180168. Patterson T, Perkins GD, Perkins A, Clayton T, Evans R, Dodd M, Robertson S, Wilson K, Mellett-Smith A, Fothergill RT, McCrone P, Dalby M, MacCarthy P, Firoozi S, Malik I, Rakhit R, Jain A, Nolan JP, Redwood SR; ARREST trial collaborators. Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trial. Lancet. 2023 Oct 14;402(10410):1329-1337. doi: 10.1016/S0140-6736(23)01351-X. Epub 2023 Aug 27. PMID: 37647928. Issa EC, Ware PJ, Bitange P, Cooper GJ, Galea T, Bengiamin DI, Young TP. The “Syringe Hickey”: An Alternative Skin Marking Method for Lumbar Puncture. J Emerg Med. 2023 Mar;64(3):400-404. doi: 10.1016/j.jemermed.2023.01.013. PMID: 37019501.

Today's show is heart felt conversation with special guest Carin Anderson of Aortic Hope: President/Co-Founder/Director of PR & AHTV.

Welcome to the AAA-Team's special episode of Join the Docs, and today, we're exploring the explosive world of abdominal aortic aneurysms (AAA) starring your favourite dynamic duo with their trusty sidekick Slim the skeleton! It's no joke - this condition is a big deal, so join Doctor Nigel Guest and Professor Jonathan Sackier and buckle up for a rib-tickling ride through the twists and turns of AAA.Your aorta, the main blood vessel supplying your gut, kidneys assorted organs, pelvis, and legs, suddenly decides to blow up like a balloon. That's what we call an abdominal aortic aneurysm. But set your funny bones aside, because if that balloon bursts, it's no party — it can be life threatening! AAA can be triggered by a variety of genetics and lifestyle choices, with smoking, high blood pressure, and sky high cholesterol levels being the usual suspects.Now, the symptoms of AAA are sneaky little devils. So what should you look out for? Chronic back pain and discomfort “downstairs” are two tell-tale signs. If not addressed, AAA can even cause sudden death! But fear not, The Docs are here to make sure you're armed and ready to tackle it head-on.Prevention and early detection are our bread and butter (well…easy on the butter). What measures can be taken, especially even for over 55s accustomed to smoking a pack of 20 cigarettes daily, or individuals with a family history of health issues, even if they seem perfectly healthy? The Docs discuss screening techniques like ultrasound and CT scans to proactively catch an abdominal aortic aneurysms (AAA) before it catches you.For the itty-bitty, less immediately serious aneurysms, it's a good idea to keep them in your peripheral vision, with regular screening. But if they start getting too big for their boots, it's time to ‘go all in' and have a surgeon visit your AAA. Whether it's performing surgery to address abdominal issues or inserting a stent to protect your arteries, rest assured, we've got the right tools to fix you up good as new.It's not all about what we can do in the operating room. Lifestyle changes are the real superheroes here. Quitting smoking, reducing your blood pressure, and keeping cholesterol levels in check are the ways to go. Hard to stomach, but worth the change.So, remember, knowledge is power! Stay on top of your health, get regular check-ups, and don't be afraid to make some changes along the way. With a bit of know-how and the right care, we'll beat AAA together and keep you laughing all the way to good health!—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship. To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocs Follow us on: x.com/JoinTheDocs

Commentary by Dr. Valentin Fuster

Coarctação da Aorta - O que eu tenho que saber? by Cardiopapers

Listener discretion is advised. PMID 27407401, 25231423, 16890849,275945 Black & Drews & Rabkin (2022). Up-to-Date.

Just in time for the holidays: adrienne maree brown and Autumn Brown join us for a heart-opening, mind-bending conversation about sisterhood, justice, family, and how to love ourselves and people with different values simultaneously.  Why their family holidays used to end in explosions – and the strategy they used to transform family time into peaceful respites. Their intentional practice for creating a more beautiful way of spending time together - including their weekly “Sister Check-ins.”  What their mother did as children to protect their dignity, and what they are doing now to protect hers. Their beautiful vision for the future – and invitation to all of us to go with them.  For our conversation with adrienne, check out 239. Why Are We Never Satisfied? With adrienne maree brown.  About adrienne:  adrienne maree brown grows healing ideas in public through writing, music, and podcasts. adrienne has nurtured Emergent Strategy, Pleasure Activism, Radical Imagination and Transformative Justice as ideas, frameworks, networks and practices for transformation. adrienne's work is informed by 25 years of social and environmental justice facilitation primarily supporting Black liberation. adrienne is the author/editor of Emergent Strategy: Shaping Change, Changing Worlds; Pleasure Activism: The Politics of Feeling Good; Grievers; and Maroons.adrienne lives in Durham, NC. TW: @adriennemaree IG:@adriennemareebrown About Autumn:  Autumn Brown is a mother, organizer, theologian, artist, and facilitator. The youngest child of an interracial marriage, rooted in the complex lineages of counter-culturalism and the military industrial complex, Autumn is a queer, mixed-race Black woman who identifies closely with her African and European lineages, and a gifted facilitator who grounds her work in healing from the trauma of oppression.  Autumn is a facilitator with the Anti-Oppression Resource & Training Alliance (AORTA), a worker-owned cooperative devoted to strengthening movements for social justice and a solidarity economy through political education, training, and planning. Prior to joining AORTA, Autumn served as the Executive Director of RECLAIM!, a non-profit that works to increase access to mental health support so that queer and trans youth may reclaim their lives from oppression in all its forms. Autumn co-hosts the podcast "How to Survive the End of the World" with her sister, adrienne maree brown. She lives in Minneapolis with her three brilliant children. IG:@autumnmeghanbrown To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Case Discussion 103 Answer: Ascending Aorta Dilation

Alexandre Maia Mascarenhas is a 5th Degree BJJ Black Belt, we've been friends and training together for close to 30 years. Alexandre is a very creative and talented musician who had a very popular group in Brazil named Manitu as well as a Music project named Xanel where he toured in Brazil for many years. He now produces and creates his own music under his name Xande which you can find on most platforms. A little over 2 years ago he had a life changing health issue. Where he tore his Aorta in his heart. He shares his story of how he used TACFIT to not only recover but also to live his best life and how it's made him a better person.

The 1ME crew welcomes the homies from Just Practice Collaborative, a training and mentoring group focused on sustaining a community of practitioners that provide community-based accountability and support structures for all parties involved with incidents and patterns of sexual, domestic, relationship, and intimate community violence. Collaborative members Shira Hassan and Deana Lewis talk through the intentionality of their design, what Transformative Justice should and shouldn't be used for, and the importance of relationship to political experimentation. SHOW NOTES Critical Resistance - https://criticalresistance.org/ INCITE - https://incite-national.org/ Fumbling Towards Repair - https://www.akpress.org/fumbling-towards-repair.html Creative Interventions Toolkit - https://www.creative-interventions.org/toolkit/ Rachel Caidor - https://just-practice.org/rachel-caidor Saving Our Own Lives by Shira Hassan - https://www.haymarketbooks.org/books/1938-saving-our-own-lives Combahee River Collective - https://www.blackpast.org/african-american-history/combahee-river-collective-statement-1977/ Are the Cops in our Heads and Hearts By Paula X. Rojas - https://sfonline.barnard.edu/paula-rojas-are-the-cops-in-our-heads-and-hearts/ Pods and Pod Mapping Worksheet by BAY AREA TRANSFORMATIVE JUSTICE COLLECTIVE - https://batjc.wordpress.com/resources/pods-and-pod-mapping-worksheet/ NAVIGATING CONFLICT IN MOVEMENT ORGANIZATIONS by AORTA - https://static1.squarespace.com/static/5e9ddc272ee6fa03a5f1ccbe/t/606249bda86e8a2d9f9902bc/1617054141617/CONFLICT+IN+MOVEMENT+ORGANIZATIONS_handout.pdf Healing Justice Lineages by Cara Page & Erica Woodland - https://www.penguinrandomhouse.com/books/710523/healing-justice-lineages-by-cara-page/ Let This Radicalize You by Kelly Hayes and Mariame Kaba - https://www.haymarketbooks.org/books/1922-let-this-radicalize-you Practicing New Worlds by Andrea Ritchie - https://www.akpress.org/practicing-new-worlds.html

The 1ME crew welcomes the homies from Just Practice Collaborative, a training and mentoring group focused on sustaining a community of practitioners that provide community-based accountability and support structures for all parties involved with incidents and patterns of sexual, domestic, relationship, and intimate community violence. Collaborative members Shira Hassan and Deana Lewis talk through the intentionality of their design, what Transformative Justice should and shouldn't be used for, and the importance of relationship to political experimentation. SHOW NOTES Critical Resistance - https://criticalresistance.org/ INCITE - https://incite-national.org/ Fumbling Towards Repair - https://www.akpress.org/fumbling-towards-repair.html Creative Interventions Toolkit - https://www.creative-interventions.org/toolkit/ Rachel Caidor - https://just-practice.org/rachel-caidor Saving Our Own Lives by Shira Hassan - https://www.haymarketbooks.org/books/1938-saving-our-own-lives Combahee River Collective - https://www.blackpast.org/african-american-history/combahee-river-collective-statement-1977/ Are the Cops in our Heads and Hearts By Paula X. Rojas - https://sfonline.barnard.edu/paula-rojas-are-the-cops-in-our-heads-and-hearts/ Pods and Pod Mapping Worksheet by BAY AREA TRANSFORMATIVE JUSTICE COLLECTIVE - https://batjc.wordpress.com/resources/pods-and-pod-mapping-worksheet/ NAVIGATING CONFLICT IN MOVEMENT ORGANIZATIONS by AORTA - https://static1.squarespace.com/static/5e9ddc272ee6fa03a5f1ccbe/t/606249bda86e8a2d9f9902bc/1617054141617/CONFLICT+IN+MOVEMENT+ORGANIZATIONS_handout.pdf Healing Justice Lineages by Cara Page & Erica Woodland - https://www.penguinrandomhouse.com/books/710523/healing-justice-lineages-by-cara-page/ Let This Radicalize You by Kelly Hayes and Mariame Kaba - https://www.haymarketbooks.org/books/1922-let-this-radicalize-you Practicing New Worlds by Andrea Ritchie - https://www.akpress.org/practicing-new-worlds.html

In this episode, we review Resuscitative endovascular balloon occlusion of the aorta (REBOA), notably dissecting the recent Jansen et al trial in JAMA. Shownotes / References:  FOAMcast.org Thanks for listening! Jeremy Faust & Lauren Westafer

Join us in addition to our favorite band, Whitmore & Josh from Aorta as we get pumped for the upcoming Fright Night 7! (that your favorite movie reviewing podcast is emceeing) We tear this movie apart while respectfully admire the it's place in slasher movie history! --- Send in a voice message: https://podcasters.spotify.com/pod/show/afterthecreditstj/message Support this podcast: https://podcasters.spotify.com/pod/show/afterthecreditstj/support

In the high-stakes world of emergency medicine, innovations continually push the boundaries of what's possible. One such groundbreaking procedure is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). Dr. Ernest E Moore, who has literally written the book on trauma surgery, teaches us what REBOA is and how it is being used to save lives in critical situations. Another episode from the Rocky Mountain Trauma and Emergency Medicine Conference.  See more on this topic from the blog post on our website: https://emspodcast.com/resuscitative-endovascular-balloon-occlusion-of-the-aorta-reboa/  

The Brown sisters sign off season six (and 2022) with a tender, silly and thorough reflection of what they learned from this year dedicated to the scholarship of bell hooks' classic text All About Love. --- Sovereignty Songs Playlist from Beloved Listener, Kira --- To learn more about AORTA's Speculative Budgeting workshop sign up for their newsletter @ aorta.coop --- SUPPORT OUR SHOW! - https://www.patreon.com/Endoftheworldshow --- TRANSCRIPT --- Music by Tunde Olaniran and Mother Cyborg --- HTS ESSENTIALS SUPPORT Our Show on Patreon https://www.patreon.com/Endoftheworldshow PEEP us on IG https://www.instagram.com/endoftheworldpc/ TWEET @ us https://twitter.com/endoftheworldPC --- Send in a voice message: https://anchor.fm/how-to-survive-the-end-of-the-world/message